Article Text

Download PDFPDF
Fragile X premutation presenting as essential tremor
  1. G Gorman1,
  2. S Fairgrieve2,
  3. D Birchall3,
  4. P F Chinnery1,4
  1. 1
    Department of Neurology, Regional Neuroscience Centre, Newcastle upon Tyne Hospitals NHS Trust, UK
  2. 2
    Department of Clinical Genetics, Institute of Human Genetics, Newcastle upon Tyne Hospitals NHS Trust, UK
  3. 3
    Department of Neuroradiology, Regional Neuroscience Centre, Newcastle upon Tyne Hospitals NHS Trust, UK
  4. 4
    Institutes of Human Genetics and Neuroscience, Newcastle University, UK
  1. Professor P F Chinnery, Mitochondrial Research Group, The Medical School, Framlington Place, Newcastle upon Tyne NE2 4HH, UK; P.F.Chinnery{at}ncl.ac.uk

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Essential tremor (ET) is one of the most common movement disorders seen in routine neurological practice, but other diseases may mimic this condition. Here we describe a 62-year-old right-handed man with an action (kinetic) tremor fulfilling diagnostic criteria for ET which was the presenting feature of the fragile X associated tremor/ataxia syndrome. His sister’s grandchildren were the clue to the diagnosis, illustrating the importance of a detailed medical history in descendents as well as ancestors in the context of late onset neurological disorders.

ET, typically a symmetric bilateral postural tremor with fluctuating amplitude, can be asymmetric and varies both in severity and functional impact. It classically begins in the fourth and fifth decades of life, is frequently associated with a family history and affects 0.8/1000 (95% confidence interval 0.5 to 1) of the general population, with a prevalence that increases with age.1 ET is one of the most common movement disorders seen in routine neurological practice, and the diagnosis is usually straightforward. The …

View Full Text

Footnotes

  • Funding: PFC is a Wellcome Trust Senior Fellow in Clinical Science who also receives funding from the Medical Research Council (UK), Parkinson’s Disease Society (UK) and United Mitochondrial Diseases Foundation.

  • Competing interests: None.

  • Ethics approval: Ethics approval was obtained.

  • Patient consent: Obtained.